Piperacillin and Tazobactam Injectable Recalled for Sterility Assurance Issue
Astral SteriTech is recalling 204,860 vials of Piperacillin and Tazobactam for Injection due to lack of assurance of sterility. The FDA classified this as a Class II recall affecting nationwide distribution.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable pharmaceutical due to lack of assurance of sterility. Although no illnesses or injuries have been reported, non-sterile injectable drugs pose a serious risk of contamination and infection. This qualifies as a risk-of-harm product without reported injury, placing it in the High severity category.
Plain-English summary
Astral SteriTech Private Ltd. is recalling all lots of Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial (NDC 72572-577-10) due to lack of assurance of sterility. The FDA classified this as a Class II recall. Non-sterile injectable medications could pose a contamination risk to patients.
The recall affects approximately 204,860 vials distributed nationwide within the United States. All lots within their expiration dates are included. The product was manufactured for Civica Inc. of Lehi, Utah.
Persons who received this product should not use it and should contact their healthcare provider. Healthcare facilities and pharmacies should verify their inventory against the NDC number and take appropriate steps to prevent distribution of affected vials.
The recalled product
- Product
- Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-577-10
- Manufacturer
- Astral SteriTech Private Ltd.
- Category
- Drug — Injectable
- Hazard
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27